Objectives: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse prevention in detoxified formerly opioid-dependent individuals compared with any strategy that does not use naltrexone, including treatment with placebo, other pharmacological treatments, psychosocial interventions or no treatment. Data sources: Major electronic databases were searched from inception to September 2005. Review methods: Selected studies were screened and quality assessed. Meta-analyses were carried out as appropriate. A decision-analytic model using Monte Carlo simulation was developed that compared naltrexone as an adjunctive therapy to no naltrexone. It assumed compliance rates that were not enhanced by contingent manageme...
UnlabelledWe aimed to assess the efficacy and safety of an injectable, once monthly extended-release...
OBJECTIVE: The objective of this selective evidence based medicine review is to determine whether or...
BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol; Alkermes Inc.) is an injectable monthly s...
Objectives: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
OBJECTIVES: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse preventio...
This systematic review summarises evidence of the effectiveness of naltrexone (NTX) and the added va...
Opioid dependence is considered to be a lifelong, chronic relapsing disorder. Substantial therapeuti...
Background: Opioid dependence is a serious and chronic disease which causes global problems. Many op...
PURPOSE: Opioid dependence (OD) is a serious and growing clinical condition with increasing social c...
Background: People recovering from heroin addiction need better treatments than are currently offere...
Aim: To assess efficacy of Naltrexone in preventing the relapse among opioid-dependent pts. Place o...
Methadone, which is a highly addictive drug. Naltrexone is a long-acting, opioid-antagonist that blo...
BACKGROUND AND AIMS: Criminal justice-involved individuals are highly susceptible to opioid relapse ...
Objective: To provide an overview of treatment options for opioid-dependent patients. Method: We scr...
UnlabelledWe aimed to assess the efficacy and safety of an injectable, once monthly extended-release...
OBJECTIVE: The objective of this selective evidence based medicine review is to determine whether or...
BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol; Alkermes Inc.) is an injectable monthly s...
Objectives: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
OBJECTIVES: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse preventio...
This systematic review summarises evidence of the effectiveness of naltrexone (NTX) and the added va...
Opioid dependence is considered to be a lifelong, chronic relapsing disorder. Substantial therapeuti...
Background: Opioid dependence is a serious and chronic disease which causes global problems. Many op...
PURPOSE: Opioid dependence (OD) is a serious and growing clinical condition with increasing social c...
Background: People recovering from heroin addiction need better treatments than are currently offere...
Aim: To assess efficacy of Naltrexone in preventing the relapse among opioid-dependent pts. Place o...
Methadone, which is a highly addictive drug. Naltrexone is a long-acting, opioid-antagonist that blo...
BACKGROUND AND AIMS: Criminal justice-involved individuals are highly susceptible to opioid relapse ...
Objective: To provide an overview of treatment options for opioid-dependent patients. Method: We scr...
UnlabelledWe aimed to assess the efficacy and safety of an injectable, once monthly extended-release...
OBJECTIVE: The objective of this selective evidence based medicine review is to determine whether or...
BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol; Alkermes Inc.) is an injectable monthly s...